Advances in Stigmasterol on its anti-tumor effect and mechanism of action

Stigmasterol is a phytosterol derived from multiple herbaceous plants such as herbs, soybean and tobacco, and it has received much attention for its various pharmacological effects including anti-inflammation, anti-diabetes, anti-oxidization, and lowering blood cholesterol. Multiple studies have rev...

Full description

Bibliographic Details
Main Authors: Xiaoyu Zhang, Jiayun Wang, Lin Zhu, Xuezhen Wang, Feifei Meng, Lei Xia, Hairong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1101289/full
_version_ 1828121092027318272
author Xiaoyu Zhang
Jiayun Wang
Lin Zhu
Xuezhen Wang
Feifei Meng
Lei Xia
Hairong Zhang
author_facet Xiaoyu Zhang
Jiayun Wang
Lin Zhu
Xuezhen Wang
Feifei Meng
Lei Xia
Hairong Zhang
author_sort Xiaoyu Zhang
collection DOAJ
description Stigmasterol is a phytosterol derived from multiple herbaceous plants such as herbs, soybean and tobacco, and it has received much attention for its various pharmacological effects including anti-inflammation, anti-diabetes, anti-oxidization, and lowering blood cholesterol. Multiple studies have revealed that stigmasterol holds promise as a potentially beneficial therapeutic agent for malignant tumors because of its significant anti-tumor bioactivity. It is reported that stigmasterol has anti-tumor effect in a variety of malignancies (e.g., breast, lung, liver and ovarian cancers) by promoting apoptosis, inhibiting proliferation, metastasis and invasion, and inducing autophagy in tumor cells. Mechanistic study shows that stigmasterol triggers apoptosis in tumor cells by regulating the PI3K/Akt signaling pathway and the generation of mitochondrial reactive oxygen species, while its anti-proliferative activity is mainly dependent on its modulatory effect on cyclin proteins and cyclin-dependent kinase (CDK). There have been multiple mechanisms underlying the anti-tumor effect of stigmasterol, which make stigmasterol promising as a new anti-tumor agent and provide insights into research on its anti-tumor role. Presently, stigmasterol has been poorly understood, and there is a paucity of systemic review on the mechanism underlying its anti-tumor effect. The current study attempts to conduct a literature review on stigmasterol for its anti-tumor effect to provide reference for researchers and clinical workers.
first_indexed 2024-04-11T14:16:03Z
format Article
id doaj.art-a50490cf405247daaad06509fcdce0be
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T14:16:03Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-a50490cf405247daaad06509fcdce0be2022-12-22T04:19:28ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.11012891101289Advances in Stigmasterol on its anti-tumor effect and mechanism of actionXiaoyu Zhang0Jiayun Wang1Lin Zhu2Xuezhen Wang3Feifei Meng4Lei Xia5Hairong Zhang6School of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, ChinaSchool of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, ChinaSchool of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, ChinaSchool of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, ChinaSchool of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, ChinaDepartment of Pathology, Shandong University of Traditional Chinese Medicine, Jinan, ChinaDepartment of Obstetrics and Gynecology, Shandong Provincial Third Hospital, Jinan, ChinaStigmasterol is a phytosterol derived from multiple herbaceous plants such as herbs, soybean and tobacco, and it has received much attention for its various pharmacological effects including anti-inflammation, anti-diabetes, anti-oxidization, and lowering blood cholesterol. Multiple studies have revealed that stigmasterol holds promise as a potentially beneficial therapeutic agent for malignant tumors because of its significant anti-tumor bioactivity. It is reported that stigmasterol has anti-tumor effect in a variety of malignancies (e.g., breast, lung, liver and ovarian cancers) by promoting apoptosis, inhibiting proliferation, metastasis and invasion, and inducing autophagy in tumor cells. Mechanistic study shows that stigmasterol triggers apoptosis in tumor cells by regulating the PI3K/Akt signaling pathway and the generation of mitochondrial reactive oxygen species, while its anti-proliferative activity is mainly dependent on its modulatory effect on cyclin proteins and cyclin-dependent kinase (CDK). There have been multiple mechanisms underlying the anti-tumor effect of stigmasterol, which make stigmasterol promising as a new anti-tumor agent and provide insights into research on its anti-tumor role. Presently, stigmasterol has been poorly understood, and there is a paucity of systemic review on the mechanism underlying its anti-tumor effect. The current study attempts to conduct a literature review on stigmasterol for its anti-tumor effect to provide reference for researchers and clinical workers.https://www.frontiersin.org/articles/10.3389/fonc.2022.1101289/fullstigmasteroltumormechanismpathwayplants
spellingShingle Xiaoyu Zhang
Jiayun Wang
Lin Zhu
Xuezhen Wang
Feifei Meng
Lei Xia
Hairong Zhang
Advances in Stigmasterol on its anti-tumor effect and mechanism of action
Frontiers in Oncology
stigmasterol
tumor
mechanism
pathway
plants
title Advances in Stigmasterol on its anti-tumor effect and mechanism of action
title_full Advances in Stigmasterol on its anti-tumor effect and mechanism of action
title_fullStr Advances in Stigmasterol on its anti-tumor effect and mechanism of action
title_full_unstemmed Advances in Stigmasterol on its anti-tumor effect and mechanism of action
title_short Advances in Stigmasterol on its anti-tumor effect and mechanism of action
title_sort advances in stigmasterol on its anti tumor effect and mechanism of action
topic stigmasterol
tumor
mechanism
pathway
plants
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1101289/full
work_keys_str_mv AT xiaoyuzhang advancesinstigmasterolonitsantitumoreffectandmechanismofaction
AT jiayunwang advancesinstigmasterolonitsantitumoreffectandmechanismofaction
AT linzhu advancesinstigmasterolonitsantitumoreffectandmechanismofaction
AT xuezhenwang advancesinstigmasterolonitsantitumoreffectandmechanismofaction
AT feifeimeng advancesinstigmasterolonitsantitumoreffectandmechanismofaction
AT leixia advancesinstigmasterolonitsantitumoreffectandmechanismofaction
AT hairongzhang advancesinstigmasterolonitsantitumoreffectandmechanismofaction